West Pharmaceutical Services, Inc. — Company profile
Healthcare · Medical Instruments & Supplies · United States
Last price 412.62 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 28.74B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.
Details
| Name | West Pharmaceutical Services, Inc. |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Employees | 10800 |
| Founded | 1923 |
| Ceo | Michel Lagarde |
| Country | United States |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US9553061055 |
| Cusip | 955306105 |
| Cik | 0000105770 |
| Sic | 3841 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Michel Lagarde | President, Chief Executive Officer and Director |
| Robert W. McMahon C.M.A. | Senior Vice President and Chief Financial Officer |
| Annette F. Favorite | Chief Human Resources Officer and Senior Vice President |
| Shane A. Campbell | SVice President and Chief Proprietary Segment Officer |
| Chad R. Winters | Vice President of Finance and Chief Accounting Officer |
| Dr. Devesh Mathur | Senior Vice President and Chief Technology Officer |
| John P. Sweeney C.F.A. | Vice President of Investor Relations |
| Norman D. Finch Jr. | Senior Vice President, General Counsel and Corporate Secretary |
| Michele Polinsky | Vice President of Global Communications |
| Rudy J. Poussot | Senior Vice President of Strategy and Corporate Development |
Contact
| Address | 530 Herman O. West Drive, Exton, Pennsylvania 19341-1147, United States |
| Phone | 610 594 2900 |
| Website | https://www.westpharma.com |